Board of Directors
In the News
Media Release: New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore
New personalised healthcare partnership formed to improve outcomes for people with cancer in Singapore Singapore Translational Cancer Consortium, National Cancer Centre Singapore, National University Hospital and Roche signed a Memorandum of Understanding (MOU) to leverage data insights and deepen understanding of unique drivers of disease to help improve health outcomes Public sector partners will provide […]
Media Coverage: Extraordinary 2020 Vaccines Speed
CRIS CEO, Dr Danny Soon, articulates why the vaccine development effort for Covid-19 has been like no other.
Media Coverage: Precision medicine key to preventing disease
Precision Health Research, Singapore (PRECISE) was incorporated to coordinate a whole-of-government effort to implement Phase II of Singapore’s 10-year precision medicine strategy.
Media Coverage: Committee for Singapore’s Covid-19 vaccination strategy
The Ministry of Health (MOH) has appointed a 14-member Expert Committee on COVID-19 Vaccination to make recommendations to the government on Singapore’s COVID-19 vaccination strategy.
Media Coverage: Paediatric Acute Respiratory Distress Syndrome (PARDS)
SCRI was featured in today’s Lianhe Zaobao on Paediatric Acute Respiratory Distress Syndrome (PARDS).
[ANNOUNCEMENT] Appointment of CEO (CRIS) and ED (SCRI)
About the Consortium for Clinical Research and Innovation Singapore (CRIS) The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly owned subsidiary of MOH Holdings, has been established in 2020 with the goal of strengthening synergies and promulgating strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry […]